Newsroom | 5235 results
Sorted by: Latest
-
WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor
MILAN--(BUSINESS WIRE)--WISE S.p.A., a pioneering medical device company specializing in advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interface (BCI), today announced the successful closing of an oversubscribed Series D financing round totaling €30 million. The round was joined by ENEA Tech and Biomedical, an Italian foundation dedicated to innovation and technology transfer in the biomedical sector, which enters WISE's investor base as a strategic pa...
-
Bayer Completes Acquisition of Perfuse Therapeutics
BERLIN--(BUSINESS WIRE)--Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously, Bayer now holds the full rights pertaining to PER-001 intravitreal implant, a first in class, sustained release small molecule endothelin receptor antagonist currently in Phase II clinical development for the treatment of Glaucoma and Diabetic Retinopathy (DR). This acquisition strengthe...
-
America's Most Talked-About Drug Has a Surprising Secret: 69% of GLP-1 Users Are Unlikely to Admit Taking It
DENVER--(BUSINESS WIRE)--Virta Health, the leader in metabolic disease reversal, today released its third annual 2026 Virta Vitals, a national survey of U.S. adults that examines Americans' evolving attitudes and behaviors toward GLP-1 medications. While GLP-1 medications have become one of the most visible health trends in America, this year’s report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one, revealing a surprising gap between public...
-
Strive Health Welcomes New Chief Medical Officer and Chief Financial Officer
DENVER--(BUSINESS WIRE)--Strive Health, the national leader in value-based kidney care, has welcomed two new members to its executive team. Jamie Sharp, M.D., has been named chief medical officer and will oversee Strive’s clinical strategy and performance. Serving as chief financial officer, Chris Rigg will drive financial strategy and operations, while helping scale the business and deploy AI technologies.“As we continue to build on Strive’s strong momentum, Jamie and Chris stood out as the rig...
-
Klick Labs Announces Vocal Biomarker Research Collaboration
TORONTO & NEW YORK--(BUSINESS WIRE)--Researchers at Klick Labs are launching a series of clinical studies with Mayo Clinic in Florida exploring the use of novel vocal biomarkers....
-
OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
MENLO PARK, Calif.--(BUSINESS WIRE)--OrsoBio presents positive Phase 2a data for its LXR inverse agonist TLC-2716 in SHTG and MASLD at ENDO 2026....
-
CMHC 2026 Unveils Conference Program, Delivers Education to Shape the Future of Cardiometabolic Care
SAN FRANCISCO--(BUSINESS WIRE)--CMHC (Cardiometabolic Health Congress), the premier forum where evidence-based innovation meets clinical practice, unveils the 2026 Conference Program. For over two decades, CMHC has united healthcare providers from around the globe to transform cutting-edge research into actionable strategies that enhance patient care. CMHC uniquely bridges the gap between groundbreaking science and real-world application, empowering a global community of clinicians to transform...
-
Cytovance Biologics Launches In-House Cell Line Development with High-Yield Titers up to 10g/L
OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics®, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its mammalian cell culture capabilities with the addition of cell line development services, strengthening its ability to provide a seamless path from DNA to IND submission for its customers. The launch of new cell line development services reflects Cytovance’s continued investment in innovati...
-
Virta Health Introduces Unified GLP-1 Access Platform for Employers
DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced an expanded menu of GLP-1 fulfillment options for employers, spanning pharmacy benefit manager (PBM), direct-to-employer (DTE), and direct-to-consumer (DTC) solutions. Virta pairs these fulfillment options with its proven Responsible Prescribing and Nutrition-first weight loss programs through which members, regardless of the fulfillment option, receive Virta’s in-house provider oversight and perso...
-
Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development
SAN FRANCISCO--(BUSINESS WIRE)--Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development...